Cargando…

Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization

Following the FDA-approval of the hematopoietic stem cell (HSC) mobilizer plerixafor, orally available and potent CXCR4 antagonists were pursued. One such proposition was AMD11070, which was orally active and had superior antagonism in vitro; however, it did not appear as effective for HSC mobilizat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jørgensen, Astrid S., Daugvilaite, Viktorija, De Filippo, Katia, Berg, Christian, Mavri, Masa, Benned-Jensen, Tau, Juzenaite, Goda, Hjortø, Gertrud, Rankin, Sara, Våbenø, Jon, Rosenkilde, Mette M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115334/ https://www.ncbi.nlm.nih.gov/pubmed/33980979 http://dx.doi.org/10.1038/s42003-021-02070-9

Ejemplares similares

Oxysterol-EBI2 signaling in immune regulation and viral infection
por: Daugvilaite, Viktorija, et al.
Publicado: (2014)

Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines
por: Hjortø, Gertrud M., et al.
Publicado: (2016)

Corrigendum: Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines
por: Hjortø, Gertrud M., et al.
Publicado: (2017)

Discovery of GPR183 Agonists Based on an Antagonist Scaffold
por: Kjær, Viktoria M. S., et al.
Publicado: (2021)

Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer
por: Brandum, Emma Probst, et al.
Publicado: (2021)

The E92K Melanocortin 1 Receptor Mutant Induces cAMP Production and Arrestin Recruitment but Not ERK Activity Indicating Biased Constitutive Signaling
por: Benned-Jensen, Tau, et al.
Publicado: (2011)

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
por: Green, Michael M. B., et al.
Publicado: (2016)

Arrestin‐independent constitutive endocytosis of GPR125/ADGRA3
por: Spiess, Katja, et al.
Publicado: (2019)

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor
por: Karpova, D, et al.
Publicado: (2013)

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience
por: Basak, Grzegorz Wladyslaw, et al.
Publicado: (2010)

Plerixafor
por: Slater, Susan
Publicado: (2012)

Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
por: Jørgensen, Astrid S., et al.
Publicado: (2019)

The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor
por: Girbl, Tamara, et al.
Publicado: (2014)

Small molecule antagonism of oxysterol-induced Epstein–Barr virus induced gene 2 (EBI2) activation()
por: Benned-Jensen, Tau, et al.
Publicado: (2013)

GPR183 Is Dispensable for B1 Cell Accumulation and Function, but Affects B2 Cell Abundance, in the Omentum and Peritoneal Cavity
por: Barington, Line, et al.
Publicado: (2022)

Three-Dimensional Explant Platform for Studies on Choroid Plexus Epithelium
por: Petersen, Natalia, et al.
Publicado: (2020)

Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants
por: Benned-Jensen, T, et al.
Publicado: (2010)

Methods for Studying Endocytotic Pathways of Herpesvirus Encoded G Protein-Coupled Receptors
por: Mavri, Maša, et al.
Publicado: (2020)

Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis
por: Mavri, Maša, et al.
Publicado: (2023)

Correction: Patterns of human and porcine gammaherpesvirus-encoded BILF1 receptor endocytosis
por: Mavri, Maša, et al.
Publicado: (2023)

Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails
por: Brandum, Emma Probst, et al.
Publicado: (2022)

The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist
por: Berg, Christian, et al.
Publicado: (2022)

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
por: Reinholdt, Linn, et al.
Publicado: (2016)

Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells
por: Kuang, Pu, et al.
Publicado: (2022)

Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition
por: Sison, Edward Allan R., et al.
Publicado: (2014)

Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients
por: Shumilov, Evgenyi, et al.
Publicado: (2019)

Molecular Characterization of Oxysterol Binding to the Epstein-Barr Virus-induced Gene 2 (GPR183)
por: Benned-Jensen, Tau, et al.
Publicado: (2012)

Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India
por: Das, Soumya, et al.
Publicado: (2022)

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients
por: Clark, R E, et al.
Publicado: (2014)

Neutrophil mobilization via plerixafor-mediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow
por: Devi, Sapna, et al.
Publicado: (2013)

Plerixafor for autologous CD34(+) cell mobilization
por: Salman, Huda, et al.
Publicado: (2011)

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers
por: Visram, Alissa, et al.
Publicado: (2018)

Rewiring host–microbe interactions and barrier function during gastrointestinal inflammation
por: Jensen, Sune K, et al.
Publicado: (2022)

Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET
por: Weiss, Ido D., et al.
Publicado: (2017)

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling
por: Berning, Philipp, et al.
Publicado: (2018)

Lung Marginated and Splenic Murine Resident Neutrophils Constitute Pioneers in Tissue-Defense During Systemic E. coli Challenge
por: Juzenaite, Goda, et al.
Publicado: (2021)

Efficacy of Afternoon Plerixafor Administration for Stem Cell Mobilization
por: El Rahi, Cynthia, et al.
Publicado: (2018)

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
por: Lagresle-Peyrou, Chantal, et al.
Publicado: (2018)

Correction: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET
por: Weiss, Ido D., et al.
Publicado: (2018)

MicroRNA‐9 inhibits growth and invasion of head and neck cancer cells and is a predictive biomarker of response to plerixafor, an inhibitor of its target CXCR4
por: Hersi, Hersi Mohamed, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_au3rnql5ncovjdeue28bn4qs49